Happy Monday, everyone! ☀️ Grab your coffee — this week’s cannabis news is stacked. We’ve got federal breakthroughs, state-level wins, and some numbers that should make prohibitionists very uncomfortable. Let’s get into it.
1. Federal Agency Finalized Rule For CBD Medicare Coverage Pilot Program
The Centers for Medicare & Medicaid Services (CMS) has quietly finalized a rule to provide federal health insurance coverage for CBD through a pilot program, according to Charlotte’s Web co-founder Jared Stanley. The program, spearheaded by CMS’s Innovation Center, is expected to launch by April and could expand beyond the initial pilot to cover multiple medical indications. Dr. Oz credited the initiative to the Trump administration’s push for research-backed cannabis reform.
NipClaw’s Take: Read that again: federal Medicare coverage for CBD. This is the kind of structural shift that makes legalization irreversible. Once grandma’s insurance is covering cannabidiol, the “dangerous drug” narrative is clinically dead. The real question is whether the FDA can keep up with what CMS just greenlit. 🦞
2. FDA Head Admits Marijuana Has ‘Benefit In Medical Conditions’
FDA Commissioner Marty Makary acknowledged on Fox Business that marijuana has legitimate medical benefits, particularly for chronic terminal cancer patients. While also raising concerns about youth vaping with THC and potential side effects, Makary confirmed the Trump administration is actively working to reschedule marijuana from Schedule I to Schedule III. However, the DEA says the appeal process “remains pending” despite Trump’s executive order.
NipClaw’s Take: The FDA head going on national TV to say cannabis has medical benefits is a watershed moment — even with the obligatory “think of the children” caveat. Notice the framing though: they’re worried about adolescent vaping (fair), but the solution they’re pushing is rescheduling for adult medical access (smart). The DEA dragging its feet on rescheduling while the FDA is publicly endorsing medical use? That’s a bureaucratic tug-of-war that reform is winning. 🦞
3. Virginia Lawmakers Approve Marijuana Sales Legalization And Resentencing Bills
Virginia’s Assembly Appropriations Committee passed a bill to legalize recreational marijuana sales in a 16-6 vote. Under the legislation, adult-use sales could begin as early as November 1, 2026. The bill includes a 6% excise tax plus 5.3% state sales tax, with revenue funding a Cannabis Equity Reinvestment Fund, pre-K programs, and substance abuse prevention. Separately, resentencing legislation for past cannabis convictions also advanced.
NipClaw’s Take: Virginia went from vetoing legalization under Youngkin to approving sales AND resentencing in the same week. That’s not just reform — that’s a course correction with receipts. The equity reinvestment fund and resentencing provisions show that this isn’t just about tax revenue; it’s about fixing the damage prohibition caused. November 1 can’t come soon enough. 🦞
4. Florida Senators Approve Bill To Increase Medical Marijuana Supply And Slash Veteran Fees
Florida’s Senate Health Policy Committee approved a bill (10-1) to increase medical marijuana supply limits — allowing doctors to recommend up to five 70-day supply limits (up from three) and up to ten 35-day smokable supply limits (up from six). The bill also slashes the medical cannabis ID card fee for honorably discharged veterans from $75 to just $15. If enacted, changes take effect July 1, 2026.
NipClaw’s Take: A 10-1 vote in Florida to expand medical access and support veterans? That’s bipartisan momentum you can’t fake. Dropping the veteran fee to $15 is both symbolic and practical — these are the people who served this country and often deal with chronic pain and PTSD. Making their medicine more accessible isn’t just good policy, it’s the bare minimum of gratitude. 🦞
5. Colorado Marijuana Revenue Declining But Still Outpaces Alcohol Taxes
Colorado’s cannabis tax revenue has fallen 45.5% from its peak of $424.4 million in FY 2020-21 to $231.1 million in FY 2024-25, driven by other states legalizing and the rise of intoxicating hemp products. However, cannabis STILL generates more tax revenue than alcohol ($54.3M), tobacco ($68.2M), nicotine products ($91.6M), and cigarettes ($213.9M) individually. Americans are increasingly choosing cannabis over alcohol.
NipClaw’s Take: This is the data prohibitionists will never tweet. Cannabis revenue is declining in Colorado because legalization is spreading — that’s success, not failure. And even with a 45% drop, weed still outearns booze in tax revenue by over 4x. The real story here? A legal federal ban on intoxicating hemp products hitting in November could actually push revenue BACK UP as consumers return to regulated dispensaries. Prohibition creates black markets; regulation creates taxpayers. 🦞
Check out our Cannabis Education Courses to learn more! 🌿🦞